Medical Care
Global Stroke Therapeutics Market Research Report 2025
- Apr 07, 25
- ID: 167624
- Pages: 92
- Figures: 99
- Views: 36
The global market for Stroke Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Stroke Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Therapeutics.
The Stroke Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stroke Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stroke Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Zocere, Inc.
Acticor Biotech
DiaMedica Therapeutics
Lumosa Therapeutics
AXONIS Therapeutics , Inc.
NovaGo Therapeutics
Segment by Type
Intravenous Injection
Oral
Others
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stroke Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Stroke Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Therapeutics.
The Stroke Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stroke Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stroke Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Zocere, Inc.
Acticor Biotech
DiaMedica Therapeutics
Lumosa Therapeutics
AXONIS Therapeutics , Inc.
NovaGo Therapeutics
Segment by Type
Intravenous Injection
Oral
Others
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stroke Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intravenous Injection
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Stroke Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stroke Therapeutics Market Perspective (2020-2031)
2.2 Global Stroke Therapeutics Growth Trends by Region
2.2.1 Global Stroke Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stroke Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Stroke Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Stroke Therapeutics Market Dynamics
2.3.1 Stroke Therapeutics Industry Trends
2.3.2 Stroke Therapeutics Market Drivers
2.3.3 Stroke Therapeutics Market Challenges
2.3.4 Stroke Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Therapeutics Players by Revenue
3.1.1 Global Top Stroke Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Stroke Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stroke Therapeutics Revenue
3.4 Global Stroke Therapeutics Market Concentration Ratio
3.4.1 Global Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Therapeutics Revenue in 2024
3.5 Global Key Players of Stroke Therapeutics Head office and Area Served
3.6 Global Key Players of Stroke Therapeutics, Product and Application
3.7 Global Key Players of Stroke Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Therapeutics Breakdown Data by Type
4.1 Global Stroke Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Stroke Therapeutics Forecasted Market Size by Type (2026-2031)
5 Stroke Therapeutics Breakdown Data by Application
5.1 Global Stroke Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Stroke Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stroke Therapeutics Market Size (2020-2031)
6.2 North America Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stroke Therapeutics Market Size by Country (2020-2025)
6.4 North America Stroke Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stroke Therapeutics Market Size (2020-2031)
7.2 Europe Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stroke Therapeutics Market Size by Country (2020-2025)
7.4 Europe Stroke Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Stroke Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stroke Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Stroke Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stroke Therapeutics Market Size (2020-2031)
9.2 Latin America Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stroke Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Stroke Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stroke Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Stroke Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Stroke Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Stroke Therapeutics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Cordis
11.2.1 Cordis Company Details
11.2.2 Cordis Business Overview
11.2.3 Cordis Stroke Therapeutics Introduction
11.2.4 Cordis Revenue in Stroke Therapeutics Business (2020-2025)
11.2.5 Cordis Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Stroke Therapeutics Introduction
11.3.4 Boston Scientific Revenue in Stroke Therapeutics Business (2020-2025)
11.3.5 Boston Scientific Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Stroke Therapeutics Introduction
11.4.4 Siemens Revenue in Stroke Therapeutics Business (2020-2025)
11.4.5 Siemens Recent Development
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Stroke Therapeutics Introduction
11.5.4 Genentech Revenue in Stroke Therapeutics Business (2020-2025)
11.5.5 Genentech Recent Development
11.6 Koninklijke Philips
11.6.1 Koninklijke Philips Company Details
11.6.2 Koninklijke Philips Business Overview
11.6.3 Koninklijke Philips Stroke Therapeutics Introduction
11.6.4 Koninklijke Philips Revenue in Stroke Therapeutics Business (2020-2025)
11.6.5 Koninklijke Philips Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Stroke Therapeutics Introduction
11.7.4 Medtronic Revenue in Stroke Therapeutics Business (2020-2025)
11.7.5 Medtronic Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Stroke Therapeutics Introduction
11.8.4 GE Healthcare Revenue in Stroke Therapeutics Business (2020-2025)
11.8.5 GE Healthcare Recent Development
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Stroke Therapeutics Introduction
11.9.4 Stryker Revenue in Stroke Therapeutics Business (2020-2025)
11.9.5 Stryker Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Stroke Therapeutics Introduction
11.10.4 Merck Revenue in Stroke Therapeutics Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Zocere, Inc.
11.11.1 Zocere, Inc. Company Details
11.11.2 Zocere, Inc. Business Overview
11.11.3 Zocere, Inc. Stroke Therapeutics Introduction
11.11.4 Zocere, Inc. Revenue in Stroke Therapeutics Business (2020-2025)
11.11.5 Zocere, Inc. Recent Development
11.12 Acticor Biotech
11.12.1 Acticor Biotech Company Details
11.12.2 Acticor Biotech Business Overview
11.12.3 Acticor Biotech Stroke Therapeutics Introduction
11.12.4 Acticor Biotech Revenue in Stroke Therapeutics Business (2020-2025)
11.12.5 Acticor Biotech Recent Development
11.13 DiaMedica Therapeutics
11.13.1 DiaMedica Therapeutics Company Details
11.13.2 DiaMedica Therapeutics Business Overview
11.13.3 DiaMedica Therapeutics Stroke Therapeutics Introduction
11.13.4 DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)
11.13.5 DiaMedica Therapeutics Recent Development
11.14 Lumosa Therapeutics
11.14.1 Lumosa Therapeutics Company Details
11.14.2 Lumosa Therapeutics Business Overview
11.14.3 Lumosa Therapeutics Stroke Therapeutics Introduction
11.14.4 Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)
11.14.5 Lumosa Therapeutics Recent Development
11.15 AXONIS Therapeutics , Inc.
11.15.1 AXONIS Therapeutics , Inc. Company Details
11.15.2 AXONIS Therapeutics , Inc. Business Overview
11.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Introduction
11.15.4 AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2020-2025)
11.15.5 AXONIS Therapeutics , Inc. Recent Development
11.16 NovaGo Therapeutics
11.16.1 NovaGo Therapeutics Company Details
11.16.2 NovaGo Therapeutics Business Overview
11.16.3 NovaGo Therapeutics Stroke Therapeutics Introduction
11.16.4 NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)
11.16.5 NovaGo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intravenous Injection
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Stroke Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stroke Therapeutics Market Perspective (2020-2031)
2.2 Global Stroke Therapeutics Growth Trends by Region
2.2.1 Global Stroke Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stroke Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Stroke Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Stroke Therapeutics Market Dynamics
2.3.1 Stroke Therapeutics Industry Trends
2.3.2 Stroke Therapeutics Market Drivers
2.3.3 Stroke Therapeutics Market Challenges
2.3.4 Stroke Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Therapeutics Players by Revenue
3.1.1 Global Top Stroke Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Stroke Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stroke Therapeutics Revenue
3.4 Global Stroke Therapeutics Market Concentration Ratio
3.4.1 Global Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Therapeutics Revenue in 2024
3.5 Global Key Players of Stroke Therapeutics Head office and Area Served
3.6 Global Key Players of Stroke Therapeutics, Product and Application
3.7 Global Key Players of Stroke Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Therapeutics Breakdown Data by Type
4.1 Global Stroke Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Stroke Therapeutics Forecasted Market Size by Type (2026-2031)
5 Stroke Therapeutics Breakdown Data by Application
5.1 Global Stroke Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Stroke Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stroke Therapeutics Market Size (2020-2031)
6.2 North America Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stroke Therapeutics Market Size by Country (2020-2025)
6.4 North America Stroke Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stroke Therapeutics Market Size (2020-2031)
7.2 Europe Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stroke Therapeutics Market Size by Country (2020-2025)
7.4 Europe Stroke Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Stroke Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stroke Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Stroke Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stroke Therapeutics Market Size (2020-2031)
9.2 Latin America Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stroke Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Stroke Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stroke Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Stroke Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Stroke Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Stroke Therapeutics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Cordis
11.2.1 Cordis Company Details
11.2.2 Cordis Business Overview
11.2.3 Cordis Stroke Therapeutics Introduction
11.2.4 Cordis Revenue in Stroke Therapeutics Business (2020-2025)
11.2.5 Cordis Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Stroke Therapeutics Introduction
11.3.4 Boston Scientific Revenue in Stroke Therapeutics Business (2020-2025)
11.3.5 Boston Scientific Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Stroke Therapeutics Introduction
11.4.4 Siemens Revenue in Stroke Therapeutics Business (2020-2025)
11.4.5 Siemens Recent Development
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Stroke Therapeutics Introduction
11.5.4 Genentech Revenue in Stroke Therapeutics Business (2020-2025)
11.5.5 Genentech Recent Development
11.6 Koninklijke Philips
11.6.1 Koninklijke Philips Company Details
11.6.2 Koninklijke Philips Business Overview
11.6.3 Koninklijke Philips Stroke Therapeutics Introduction
11.6.4 Koninklijke Philips Revenue in Stroke Therapeutics Business (2020-2025)
11.6.5 Koninklijke Philips Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Stroke Therapeutics Introduction
11.7.4 Medtronic Revenue in Stroke Therapeutics Business (2020-2025)
11.7.5 Medtronic Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Stroke Therapeutics Introduction
11.8.4 GE Healthcare Revenue in Stroke Therapeutics Business (2020-2025)
11.8.5 GE Healthcare Recent Development
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Stroke Therapeutics Introduction
11.9.4 Stryker Revenue in Stroke Therapeutics Business (2020-2025)
11.9.5 Stryker Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Stroke Therapeutics Introduction
11.10.4 Merck Revenue in Stroke Therapeutics Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Zocere, Inc.
11.11.1 Zocere, Inc. Company Details
11.11.2 Zocere, Inc. Business Overview
11.11.3 Zocere, Inc. Stroke Therapeutics Introduction
11.11.4 Zocere, Inc. Revenue in Stroke Therapeutics Business (2020-2025)
11.11.5 Zocere, Inc. Recent Development
11.12 Acticor Biotech
11.12.1 Acticor Biotech Company Details
11.12.2 Acticor Biotech Business Overview
11.12.3 Acticor Biotech Stroke Therapeutics Introduction
11.12.4 Acticor Biotech Revenue in Stroke Therapeutics Business (2020-2025)
11.12.5 Acticor Biotech Recent Development
11.13 DiaMedica Therapeutics
11.13.1 DiaMedica Therapeutics Company Details
11.13.2 DiaMedica Therapeutics Business Overview
11.13.3 DiaMedica Therapeutics Stroke Therapeutics Introduction
11.13.4 DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)
11.13.5 DiaMedica Therapeutics Recent Development
11.14 Lumosa Therapeutics
11.14.1 Lumosa Therapeutics Company Details
11.14.2 Lumosa Therapeutics Business Overview
11.14.3 Lumosa Therapeutics Stroke Therapeutics Introduction
11.14.4 Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)
11.14.5 Lumosa Therapeutics Recent Development
11.15 AXONIS Therapeutics , Inc.
11.15.1 AXONIS Therapeutics , Inc. Company Details
11.15.2 AXONIS Therapeutics , Inc. Business Overview
11.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Introduction
11.15.4 AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2020-2025)
11.15.5 AXONIS Therapeutics , Inc. Recent Development
11.16 NovaGo Therapeutics
11.16.1 NovaGo Therapeutics Company Details
11.16.2 NovaGo Therapeutics Business Overview
11.16.3 NovaGo Therapeutics Stroke Therapeutics Introduction
11.16.4 NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)
11.16.5 NovaGo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stroke Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Stroke Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stroke Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Stroke Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Stroke Therapeutics Market Share by Region (2020-2025)
Table 9. Global Stroke Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Stroke Therapeutics Market Share by Region (2026-2031)
Table 11. Stroke Therapeutics Market Trends
Table 12. Stroke Therapeutics Market Drivers
Table 13. Stroke Therapeutics Market Challenges
Table 14. Stroke Therapeutics Market Restraints
Table 15. Global Stroke Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Stroke Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2024)
Table 18. Ranking of Global Top Stroke Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Stroke Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Stroke Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Stroke Therapeutics, Product and Application
Table 22. Global Key Players of Stroke Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Stroke Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Stroke Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Stroke Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Stroke Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Stroke Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Stroke Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Stroke Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Stroke Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Stroke Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Stroke Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Stroke Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Laboratories Company Details
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Stroke Therapeutics Product
Table 50. Abbott Laboratories Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Cordis Company Details
Table 53. Cordis Business Overview
Table 54. Cordis Stroke Therapeutics Product
Table 55. Cordis Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Cordis Recent Development
Table 57. Boston Scientific Company Details
Table 58. Boston Scientific Business Overview
Table 59. Boston Scientific Stroke Therapeutics Product
Table 60. Boston Scientific Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Boston Scientific Recent Development
Table 62. Siemens Company Details
Table 63. Siemens Business Overview
Table 64. Siemens Stroke Therapeutics Product
Table 65. Siemens Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Siemens Recent Development
Table 67. Genentech Company Details
Table 68. Genentech Business Overview
Table 69. Genentech Stroke Therapeutics Product
Table 70. Genentech Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Genentech Recent Development
Table 72. Koninklijke Philips Company Details
Table 73. Koninklijke Philips Business Overview
Table 74. Koninklijke Philips Stroke Therapeutics Product
Table 75. Koninklijke Philips Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Koninklijke Philips Recent Development
Table 77. Medtronic Company Details
Table 78. Medtronic Business Overview
Table 79. Medtronic Stroke Therapeutics Product
Table 80. Medtronic Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Medtronic Recent Development
Table 82. GE Healthcare Company Details
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Stroke Therapeutics Product
Table 85. GE Healthcare Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 86. GE Healthcare Recent Development
Table 87. Stryker Company Details
Table 88. Stryker Business Overview
Table 89. Stryker Stroke Therapeutics Product
Table 90. Stryker Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Stryker Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Stroke Therapeutics Product
Table 95. Merck Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Zocere, Inc. Company Details
Table 98. Zocere, Inc. Business Overview
Table 99. Zocere, Inc. Stroke Therapeutics Product
Table 100. Zocere, Inc. Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 101. Zocere, Inc. Recent Development
Table 102. Acticor Biotech Company Details
Table 103. Acticor Biotech Business Overview
Table 104. Acticor Biotech Stroke Therapeutics Product
Table 105. Acticor Biotech Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Acticor Biotech Recent Development
Table 107. DiaMedica Therapeutics Company Details
Table 108. DiaMedica Therapeutics Business Overview
Table 109. DiaMedica Therapeutics Stroke Therapeutics Product
Table 110. DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 111. DiaMedica Therapeutics Recent Development
Table 112. Lumosa Therapeutics Company Details
Table 113. Lumosa Therapeutics Business Overview
Table 114. Lumosa Therapeutics Stroke Therapeutics Product
Table 115. Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 116. Lumosa Therapeutics Recent Development
Table 117. AXONIS Therapeutics , Inc. Company Details
Table 118. AXONIS Therapeutics , Inc. Business Overview
Table 119. AXONIS Therapeutics , Inc. Stroke Therapeutics Product
Table 120. AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 121. AXONIS Therapeutics , Inc. Recent Development
Table 122. NovaGo Therapeutics Company Details
Table 123. NovaGo Therapeutics Business Overview
Table 124. NovaGo Therapeutics Stroke Therapeutics Product
Table 125. NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 126. NovaGo Therapeutics Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Stroke Therapeutics Picture
Figure 2. Global Stroke Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stroke Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Intravenous Injection Features
Figure 5. Oral Features
Figure 6. Others Features
Figure 7. Global Stroke Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Stroke Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Ischemic Stroke Case Studies
Figure 10. Hemorrhagic Stroke Case Studies
Figure 11. Transient Ischemic Attack Case Studies
Figure 12. Stroke Therapeutics Report Years Considered
Figure 13. Global Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Stroke Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Stroke Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Stroke Therapeutics Market Share by Players in 2024
Figure 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Stroke Therapeutics Revenue in 2024
Figure 19. North America Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Stroke Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Stroke Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Stroke Therapeutics Market Share by Region (2020-2031)
Figure 33. China Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Stroke Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Stroke Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 49. Cordis Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 50. Boston Scientific Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 51. Siemens Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 52. Genentech Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 53. Koninklijke Philips Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 54. Medtronic Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 56. Stryker Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 58. Zocere, Inc. Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 59. Acticor Biotech Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 60. DiaMedica Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 61. Lumosa Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 62. AXONIS Therapeutics , Inc. Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 63. NovaGo Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Stroke Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Stroke Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stroke Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Stroke Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Stroke Therapeutics Market Share by Region (2020-2025)
Table 9. Global Stroke Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Stroke Therapeutics Market Share by Region (2026-2031)
Table 11. Stroke Therapeutics Market Trends
Table 12. Stroke Therapeutics Market Drivers
Table 13. Stroke Therapeutics Market Challenges
Table 14. Stroke Therapeutics Market Restraints
Table 15. Global Stroke Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Stroke Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2024)
Table 18. Ranking of Global Top Stroke Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Stroke Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Stroke Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Stroke Therapeutics, Product and Application
Table 22. Global Key Players of Stroke Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Stroke Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Stroke Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Stroke Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Stroke Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Stroke Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Stroke Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Stroke Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Stroke Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Stroke Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Stroke Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Stroke Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Laboratories Company Details
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Stroke Therapeutics Product
Table 50. Abbott Laboratories Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Cordis Company Details
Table 53. Cordis Business Overview
Table 54. Cordis Stroke Therapeutics Product
Table 55. Cordis Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Cordis Recent Development
Table 57. Boston Scientific Company Details
Table 58. Boston Scientific Business Overview
Table 59. Boston Scientific Stroke Therapeutics Product
Table 60. Boston Scientific Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Boston Scientific Recent Development
Table 62. Siemens Company Details
Table 63. Siemens Business Overview
Table 64. Siemens Stroke Therapeutics Product
Table 65. Siemens Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Siemens Recent Development
Table 67. Genentech Company Details
Table 68. Genentech Business Overview
Table 69. Genentech Stroke Therapeutics Product
Table 70. Genentech Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Genentech Recent Development
Table 72. Koninklijke Philips Company Details
Table 73. Koninklijke Philips Business Overview
Table 74. Koninklijke Philips Stroke Therapeutics Product
Table 75. Koninklijke Philips Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Koninklijke Philips Recent Development
Table 77. Medtronic Company Details
Table 78. Medtronic Business Overview
Table 79. Medtronic Stroke Therapeutics Product
Table 80. Medtronic Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Medtronic Recent Development
Table 82. GE Healthcare Company Details
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Stroke Therapeutics Product
Table 85. GE Healthcare Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 86. GE Healthcare Recent Development
Table 87. Stryker Company Details
Table 88. Stryker Business Overview
Table 89. Stryker Stroke Therapeutics Product
Table 90. Stryker Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Stryker Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Stroke Therapeutics Product
Table 95. Merck Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Zocere, Inc. Company Details
Table 98. Zocere, Inc. Business Overview
Table 99. Zocere, Inc. Stroke Therapeutics Product
Table 100. Zocere, Inc. Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 101. Zocere, Inc. Recent Development
Table 102. Acticor Biotech Company Details
Table 103. Acticor Biotech Business Overview
Table 104. Acticor Biotech Stroke Therapeutics Product
Table 105. Acticor Biotech Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Acticor Biotech Recent Development
Table 107. DiaMedica Therapeutics Company Details
Table 108. DiaMedica Therapeutics Business Overview
Table 109. DiaMedica Therapeutics Stroke Therapeutics Product
Table 110. DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 111. DiaMedica Therapeutics Recent Development
Table 112. Lumosa Therapeutics Company Details
Table 113. Lumosa Therapeutics Business Overview
Table 114. Lumosa Therapeutics Stroke Therapeutics Product
Table 115. Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 116. Lumosa Therapeutics Recent Development
Table 117. AXONIS Therapeutics , Inc. Company Details
Table 118. AXONIS Therapeutics , Inc. Business Overview
Table 119. AXONIS Therapeutics , Inc. Stroke Therapeutics Product
Table 120. AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 121. AXONIS Therapeutics , Inc. Recent Development
Table 122. NovaGo Therapeutics Company Details
Table 123. NovaGo Therapeutics Business Overview
Table 124. NovaGo Therapeutics Stroke Therapeutics Product
Table 125. NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)
Table 126. NovaGo Therapeutics Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Stroke Therapeutics Picture
Figure 2. Global Stroke Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stroke Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Intravenous Injection Features
Figure 5. Oral Features
Figure 6. Others Features
Figure 7. Global Stroke Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Stroke Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Ischemic Stroke Case Studies
Figure 10. Hemorrhagic Stroke Case Studies
Figure 11. Transient Ischemic Attack Case Studies
Figure 12. Stroke Therapeutics Report Years Considered
Figure 13. Global Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Stroke Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Stroke Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Stroke Therapeutics Market Share by Players in 2024
Figure 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Stroke Therapeutics Revenue in 2024
Figure 19. North America Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Stroke Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Stroke Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Stroke Therapeutics Market Share by Region (2020-2031)
Figure 33. China Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Stroke Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Stroke Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 49. Cordis Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 50. Boston Scientific Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 51. Siemens Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 52. Genentech Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 53. Koninklijke Philips Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 54. Medtronic Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 56. Stryker Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 58. Zocere, Inc. Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 59. Acticor Biotech Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 60. DiaMedica Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 61. Lumosa Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 62. AXONIS Therapeutics , Inc. Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 63. NovaGo Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232